Chovanec, Peter
Collier, Amanda J. https://orcid.org/0000-0003-1137-6874
Krueger, Christel https://orcid.org/0000-0001-5601-598X
VĂ¡rnai, Csilla https://orcid.org/0000-0003-0048-9507
Semprich, Claudia I. https://orcid.org/0000-0002-2446-9028
Schoenfelder, Stefan https://orcid.org/0000-0002-3200-8133
Corcoran, Anne E. https://orcid.org/0000-0002-9577-5313
Rugg-Gunn, Peter J. https://orcid.org/0000-0002-9601-5949
Funding for this research was provided by:
RCUK | Biotechnology and Biological Sciences Research Council (BBS/E/B/000C0421, BBS/E/B/000C0422, BB/J004480/1, BBS/E/B/000C0404, BBS/E/B/000C0405, BBS/E/B/000C0427, BBS/E/B/000C0428, 1520397)
RCUK | Medical Research Council (MR/J003808/1, MR/T016787/1)
Article History
Received: 25 May 2020
Accepted: 5 March 2021
First Online: 7 April 2021
Competing interests
: S.S. is a co-founder of Enhanc3D Genomics Ltd. The remaining authors declare no competing interests.